glp 1 beverage GLP‑1 functional drinks market set for rapid global growth GLP-1 Support Drink Mix ·

Between 30 million and 50 million US adults could be taking a GLP-1 by 2034. In December 2024, 1.9 million prescriptions of GLP-1s to treat obesity (as opposed to diabetes, for example) were filled, nearly quadruple the number YoY, per IQVIA

However, small benign insulinomas are difficult to detect using SRS

This temporary allowance enabled pharmacies to meet surging demand, particularly among patients seeking anti-obesity medications who now represent approximately 83% of the compounded GLP-1 market

Convenient single-serve options

The pharmacy benefit manager announced it will cover Lillys Foundayo starting June 1 and Zepbound starting in October, a setback of sorts for rival Novo Nordisk as Wegovy has been preferred.